Comments
Loading...

ProShares Ultra Nasdaq Biotechnology

BIBNASDAQ
Logo brought to you by Benzinga Data
$66.68
-0.58-0.86%
At Close: -
$64.87
-1.81-2.71%
After Hours: Sep 12, 8:15 AM EDT
15 minutes delayed
Sector
Healthcare
Region
US
AUM
88.71M
Fund Score

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Quotes, Forecast and News Summary

ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB) stock price, news, charts, stock research, profile.

Open$67.23
High$68.50
52 Wk High$69.56
AUM88.71M
Dividend$0.46
Ex-Div DateJun 26, 2024
Volume9.5K
Market Cap$53.96B
Mgmt Fee0.75%
P/E Ratio20.22
Prev. Close$67.26
Low$66.60
52 Wk Low$40.10
Shares Out1.63M
Yield0.74%
Div. FreqQuarterly
Avg. Volume Daily16.03K
Beta1.40
Avg. Expense Ratio0.95%
P/B Ratio2.12

FAQ

Q

How do I buy ProShares Ultra Nasdaq Biotechnology (BIB) stock?

A

You can purchase shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ProShares Ultra Nasdaq Biotechnology (BIB) competitors?

A

There are no as such competitors for ProShares Ultra Nasdaq Biotechnology.

Q

What is the forecast, or price target, for ProShares Ultra Nasdaq Biotechnology (BIB) stock?

A

There is no analysis for ProShares Ultra Nasdaq Biotechnology to provide a consensus price target.

Q

What is the current price for ProShares Ultra Nasdaq Biotechnology (BIB)?

A

The stock price for ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB) is $64.87 last updated September 12, 2024 at 8:15 AM EDT.

Q

Does ProShares Ultra Nasdaq Biotechnology (BIB) pay a dividend?

A

A quarterly cash dividend of 0.09 per share of Class A Common Stock. The quarterly cash dividend was payable on September 28, 2010 to stockholders of record on September 21, 2010.

Q

When is ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) reporting earnings?

A

ProShares Ultra Nasdaq Biotechnology does not have any upcoming earnings scheduled.

Q

Is ProShares Ultra Nasdaq Biotechnology (BIB) going to split?

A

There is no upcoming split for ProShares Ultra Nasdaq Biotechnology.

ETF Details
SectorHealthcare
CategoryMid Performer-Mid Growth
Investment StyleTrading-Leveraged Equity
Fund InceptionApr 6, 2010
Managers
Tarak Dave
Michael Neches
DefinitionMost of the stocks in this Equity Fund have average financial performance and average growth potential
Investment Policy
The Fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target.
Top ETF Holdings
SymbolNameShare %
GILDGilead Sciences Inc5.60%
REGNRegeneron Pharmaceutic...5.21%
VRTXVertex Pharmaceuticals...5.15%
AMGNAmgen Inc.5.14%